# | Date | Analyst Firm | Upside/Downside | Price Target Change | Rating Change | Current Rating |
---|
Edesa Biotech (NASDAQ:EDSA) reported quarterly losses of $(0.25) per share which beat the analyst consensus estimate of $(0.29)...
-SEC Filing
HC Wainwright & Co. analyst Yi Chen assumes Edesa Biotech (NASDAQ:EDSA) with a Buy rating and announces Price Target of $5.
Edesa Biotech (NASDAQ:EDSA) reported quarterly losses of $(0.30) per share which missed the analyst consensus estimate of $(0.2...
HC Wainwright & Co. analyst Vernon Bernardino reiterates Edesa Biotech (NASDAQ:EDSA) with a Buy and maintains $21 price ...